Zoetis Inc Class A

ZTS: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
LOCK|#%LOCK|?%BLOCK|%>K!fhR

Zoetis Earnings: Mixed Quarterly Results Keep Zoetis on Track for 2025

Zoetis reported second-quarter results that included reported revenue and earnings growth of 4% and 15%, respectively. Adjusted for the sale of the medicated feed additives and foreign currency, quarterly sales grew 8% year over year.

Sponsor Center